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1. Glossary of Terms 
Abnormal test 
result 
ƚĞƐƚƌĞƐƵůƚǁŚĞƌĞĂŶŽƌŵĂů ?ƉĂƐƐ ?ƌĞƐƉŽŶƐĞĐŽƵůĚŶŽƚďĞ
detected under good conditions. The result on screening 
ĞƋƵŝƉŵĞŶƚŵĂǇŝŶĚŝĐĂƚĞ ?ŶŽƌĞƐƉŽŶƐĞ ? ? ?ĨĂŝů ? ?Žƌ ?ƌĞĨĞƌ  ?
Attendance rate The proportion of all those invited for screening that are tested 
and receive a result: 
 
x Invited for screening includes all those that are offered the 
screening test. 
x dĞƐƚĞĚĂŶĚƌĞĐĞŝǀĞĂƌĞƐƵůƚĐŽƵůĚďĞĂ ?ƉĂƐƐ ?Žƌ ?ƌĞĨĞƌƌĂůƚŽ
ĚŝĂŐŶŽƐƚŝĐĂƐƐĞƐƐŵĞŶƚ ? ? 
 
Attendance rate provides information on the willingness of families 
to participate in screening. 
Compliance with 
referral 
(percentage) 
The percentage of those who are referred from screening to a 
diagnostic assessment that actually attend the diagnostic 
assessment. 
 
Percentage of compliance provides information on the willingness 
of families to attend the diagnostic assessment after referral from 
screening. 
Coverage The proportion of those eligible for screening that are tested and 
receive a result: 
 
x Eligible for screening includes those within the population 
that are covered under the screening or health care 
programme. 
x Tested and receive a ƌĞƐƵůƚĐŽƵůĚďĞĂ ?ƉĂƐƐ ?Žƌ ?ƌĞĨĞƌƚŽ
ĚŝĂŐŶŽƐƚŝĐĂƐƐĞƐƐŵĞŶƚ ? ? 
 
Factors such as being offered screening, willingness to participate, 
missed screening, ability to complete the screen, and ability to 
document the screening results will influence the coverage. 
 
False negatives The percentage of children with a visual deficit (defined by the 
ƚĂƌŐĞƚĐŽŶĚŝƚŝŽŶ ?ƚŚĂƚƌĞĐĞŝǀĞĂƌĞƐƵůƚŽĨ ?ƉĂƐƐ ?ĚƵƌŝŶŐƐĐƌĞĞŶŝŶŐ ? 
 
Example: If 100 children with visual deficit are screened, and 1 
child passes the screening, the percentage of false negatives is 1%. 
False positives The percentage of children with normal vision that are referred 
from screening to a diagnostic assessment. 
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Guidelines Recommendations or instructions provided by an authoritative 
body on the practice of screening in the country or region. 
Vision screening 
professional 
A person qualified to perform vision screening, according to the 
practice in the country or region. 
Inconclusive test 
result 
ƚĞƐƚƌĞƐƵůƚǁŚĞƌĞĂŶŽƌŵĂů ?ƉĂƐƐ ?ƌĞƐƉŽŶƐĞĐŽƵůĚŶŽƚďĞ
detected due to poor test conditions or poor cooperation of the 
child.  
Invited for 
screening 
Infants/children and their families who are offered screening. 
Outcome of vision 
screening 
An indication of the effectiveness or performance of screening, 
such as a measurement of coverage rate, referral rate, number of 
children detected, etc. 
Untreated 
amblyopia 
Those children who have not received treatment for amblyopia 
due to missed screening or missed follow-up appointment. 
Persistent 
amblyopia 
Amblyopia that is missed by screening, or present after the child 
has received treatment. 
 
 
Positive predictive 
value 
The percentage of children referred from screening who have a 
confirmed vision loss. 
 
For example, if 100 babies are referred from screening for 
diagnostic assessment and 10 have normal vision and 90 have a 
confirmed visual defect, the positive predictive value would be 
90%. 
Prevalence The percentage or number of individuals with a specific disease or 
condition. Prevalence can either be expressed as a percentage or 
as a number out of 1000 individuals within the same demographic. 
Programme An organised system for screening, which could be based 
nationally, regionally or locally. 
Protocol Documented procedure or sequence for screening, which could 
include which tests are performed, when tests are performed, 
procedures for passing and referring, and so forth. 
Quality assurance A method for checking and ensuring that screening is functioning 
adequately and meeting set goals and benchmarks. 
Referral criteria A pre-determined cut-off boundary for when achild should be re-
tested or seen for a diagnostic assessment.  
Risk babies / Babies 
at-risk 
All infants that are considered to be at-risk or have risk-factors for 
vision defects/ophthalmic pathology according to the screening 
programme. 
 
Two common risk factors are admission to the neonatal-intensive 
care unit (NICU) or born prematurely. However, other risk factors 
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for visual defects may also be indicated in the screening 
programme. 
Sensitivity The percentage of children with visual defects that are identified 
via the screening programme. 
 
For example, if 100 babies with visual defects are tested, and 98 of 
these babies are referred for diagnostic assessment and 2 pass the 
screening, the sensitivity is 98%. 
Specificity The percentage of children with normal vision that pass the 
screening. 
 
For example, if 100 babies with normal vision are tested, and 10 of 
these babies are referred for diagnostic assessment and90 pass the 
screening, the specificity is 90%. 
Target condition The visual defect you are aiming to detect via the screening 
programme. 
Well, healthy 
babies 
Infants who are not admitted into the NICU or born prematurely 
(born after a gestation period of less than 37 weeks).  
 
  
Version 2. 
Summary Vision Screening Data: Austria                                                                                          
vi 
 
2. Abbreviations 
CSA - Consilium Strabologicum Austriacum 
GDP  ? Gross Domestic Product 
HTA  ? Health Technology Assessment 
NICU  ? Neonatal-intensive care unit 
PPP  ? Purchasing Power Parity 
WHO  ? Word Health Organisation  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Version 2. 
Summary Vision Screening Data: Austria                                                                                          
1 
 
3. Population and Healthcare Overview 
The population of Austria is 8,809,202 (World Bank, 2018a) and birth rate is estimated at 
10 births/1,000 population in 2016 (World Bank, 2018b). The change in population and 
birth rate from 1960 to 2017 is shown in Figure 1, graphs A and B respectively. 
Austria has a reported population density of 106.75 people per square kilometre in 2017 
and this has risen from 85.81 people per square kilometre in 1961 (World Bank, 2018c). 
Infant mortality in 2017 was estimated at 2.9 deaths/1,000 live births in total (World Bank, 
2018d). 
The average life expectancy in Austria is estimated at 81.9 years (World Bank, 2018e), with 
a death rate of 9.2 deaths/1,000 population in 2016 (World Bank, 2018f). Austria has a 
gross national income per capita (PPP int. $, 2013) of $43,000 (WHO, 2016). The estimated 
total expenditure on health per capita in 2014 was $5,039 (Intl $) and the total expenditure 
on health in 2014 as percentage of GDP was 11.2% (WHO, 2016). 
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Figure 1: Change in the Total Population and Birth Rate in Austria between 1960 and 2017 
 
Source: Information sourced from World Bank (2018) 
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4. Vision Screening Commissioning and Guidance 
Vision screening in Austria, is organised nationally, with nine regions individually organising 
kindergarten projects. The nine regions are Burgenland, Carinthia, Lower Austria, Upper 
Austria, Salzburg, Styria, Tyrol, Vorarlberg and Vienna. These kindergarten projects include 
vision screening by photorefractors, which are organised by the kindergarden itself, the 
federal government, or photoscreener distributers. 
In Austria, each pregnant woman is given a mother-child health passport. This allows the 
doctor to enter all important examinations up to the age of 5-years. This procedure is the 
same in all 9 regions, although the execution of the recommended screening examinations 
might differ as these are only recommendations, not guidelines.  
The national vision screening programme is embedded into a general preventative child 
health care screening system. Ophthalmologists, paediatricians, general practitioners (GP) 
and opticians conduct vision screening. There are 1355 paediatricians, 926 
ophthalmologists, 14,130 GPs within Austria, it is unknown how many opticians there are. 
No other general health professionals have been identified who currently do not perform 
vision screening but could do so with additional training. There is no specific training 
available. Vision screening takes place within hospitals or in the offices of an 
ophthalmologist, paediatrician or GP.  
Vision screening is funded either privately or throug, the mother child pass programe which 
provides health care funded two-thirds from federal funds and one-third from social 
security funds. Additional projects are funded by non-profit organisations, the federal 
government, or the distributers of photoscreeners.  
The content and any reviews of the vision screening programme are decided upon by a 
Mother-Child-Passport Programme expert group.  These revisions are undertaken by the 
Ministry of Health according to actual data, reviews and Health Technology Assessments 
(HTAs). The vision screening programme was implemented nationally in 1974 as part of 
general screening. This was updated in 1987 with the addition of ophthalmic examinations. 
dŚĞƌĞ ĂƌĞ ŶŽ ƐƉĞĐŝĨŝĐ ŐƵŝĚĞůŝŶĞƐ ĨŽƌ ǀŝƐŝŽŶ ƐĐƌĞĞŶŝŶŐ ? ďƵƚ ƚŚĞƌĞ ĂƌĞ ƐŽŵĞ  ?ůŽǁ-ůĞǀĞů ?
recommendations from the Consilium Strabologicum Austriacum (CSA), a team of specialists 
from the Austrian Ophthalmological Association. There are methods for quality monitoring 
imposed by the government determined according to actual data collected, reviews of 
literature, HTAs and expert opinion.  
There is no research carried out in Austria regarding the vision screening programme. 
However, there have been cost-effectiveness analyses about the vision screening 
programme, but this is for local/regional projects only; there is no information available 
about these analyses.  
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5. Screening programme  
In Austria, anomalies of the eye, amblyopia and pathologies are screened for by vision 
screening. The health care professionals delivering vision screening, venue for screening and 
tests used vary depending on the age of the child as shown in Tables 1, 2 and 3 respectively. 
Specific details of the screening offered within each age group are described more fully in 
sections 5.1 to 5.4 below. 
5.1 Vision screening - Preterm babies 
Preterm babies are screened by ophthalmologists using retinal examination (indirect 
ophthalmoscopy). This is conducted within departments of neonatology at children 
hospitals. The number of abnormal or inconclusive test results before referral for further 
diagnostic examination are not specified, this is at the discretion of the screener. Referral 
criteria for preterm babies is based on literature, there are no specified guidelines.   
5.2 Vision screening - Birth to 3 months 
 Screening takes place at ages 1 week and then again between 4 to 7 weeks. Vision 
screening is conducted at the offices of either a paediatrician or GP, or in hospitals.  The 
Bruckner red reflex fundus test and eye inspection are recommended for well, healthy 
babies up to the age of 3 months; however, some clinicians use only a flashlight. Any 
abnormality in visual behaviour, including red reflex, strabismus, or the anatomy of the eye 
will result in the child being referred. The number of abnormal test results that necessitate a 
baby being referred is not defined, it is entirely dependent upon the clinician; the same is 
true for inconclusive tests, it is at the discretion of the clinician.  
5.3 Vision screening - 3 months to 36 months 
Children aged between 3 and 36 months of age are screened four times by a paediatrician, 
or GP at either the paediatricians office or hospital. Children are tested between 3 and 5 
months of age, then again between 7 to 9 months, 10 to 14 months. Children aged 24 
month are screened by an ophthalmologist. The tests conducted include eye inspection, red 
reflex, fixation, eye motility, retinal examination, pursuit movements, cover test and they 
are also screened for risk factors using automated devices (see Section 7). The referral 
criteria are stated as any abnormality in visual behaviour, red reflex, strabismus, or the 
anatomy of the eye.  
5.4 Vision screening - 36 months to 7 years 
Paediatricians, GPs, ophthalmologists, orthoptists, or opticians conduct vision screening in 
either the paediatricians office, hospital, or at school. The sequence of vision screening in 
children aged between 36 months and 7 years is at 34-38 months, then again at 46 to 50 
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months, and again between 58 and 62 months. The recommended tests conducted at this 
age include visual acuity measurement, stereopsis and accommodation. Visual acuity is 
measured from the age of 3 years by a paediatricians, GP or ophthalmologist. Lea symbols 
are recommended as the optotype chart to be used during this visual acuity measurement, 
but there are no specific guidelines, and therefore some clinicians may use different visual 
acuity test. Children are referred immediately after an abnormal test, although there is no 
defined protocol for how many inconclusive tests determine a referral. Referral criteria is 
stated as any abnormality in visual behaviour, red reflex, strabismus, or the anatomy of the 
eye.  
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Table 1: Healthcare professionals who conduct vision screening in each age group 
 
Table 1 
Paediatrician Ophthalmologist Orthoptist GP Optician 
Preterm babies  × 9 × × × 
0 to 3 months  9 × × 9 × 
3 to 36 months  9 9 
× 
 
 
9 × 
3 to 7 years  9 9 9 9 9 
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Table 2: Vision screening tests used in vision screening for each age group  
Table 2 
Eye 
inspection 
Red reflex 
testing 
Fixation Eye 
motility 
Retinal 
examination 
Pursuit 
movements 
Cover 
test 
Autorefraction Visual acuity 
measurement 
Preterm 
babies  
× × × × 9 × × × × 
0 to 3 
months  
9 9 × × × × × × × 
3 to 36 
months  
9 9 9 9 9 9 9 × × 
3 to 7 years  9 × × × × × 9 9 9 
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Table 3: Location of vision screening for each age group  
Table 3 Hospital Paediatrician office School 
Preterm babies  9 × × 
0 to 3 months  9 9 × 
3 to 36 months  9 9 × 
3 to 7 years  9 9 9 
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6. Automated Screening 
Automated vision screening is achieved using handheld, portable devices designed to detect 
presence of refractive error in infants from 6 months of age. It provides objective results 
and is used to detect amblyopic risk factors. This differs from other methods used to screen 
children for amblyopia which focus on detection of the actual condition and the resulting 
visual loss.  
In the nine regions where kindergarten projects are funded, automated vision screening 
devices are utilised, specifically, the PlusOptix device. Handheld automated devices are 
being more frequently utilised by ophthalmologists from the age of one year , paediatricans 
and opticans use these at older ages. There are no clear criteria or offical recommendations 
in terms of utilisation, age of testing or frequency of the automated screening. 
Each PlusOptix device costs approximately 9000 Euros and there are no maintenance costs 
due to it being computer adapted. The device should be replaced every 5 years, depending 
on new developments.   
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7. Provision for Visually Impaired  
There are three schools in Austria for severely visually impaired or blind children. Children 
with less severe visual impairment are integrated into the mainstream educational system  ? 
it is not clear if these children receive special support. Depending on the type of school, the 
overall costs are estimated at between 8,000 to 10,000 Euro per child, and technical 
equipment costing between 15,000 to 20,000 Euro. 
The decision as to which children attend the visually impaired shools, and which children are 
integrated into mainstream education is made by the director of the schools.  There is no 
structred assessment to inform this decision. 
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8. Knowledge of existing screening programme 
8.1 Prevalence/Diagnosis  
The prevalence of treated or untreated amblyopia by the age of 7 is unknown.  The  
prevalence of persistent amblyopia in Austria is also unknown. The prevalence of strabismus 
and the incidence of the four types of amblyopia (strabismic, refractive, combined-
mechanism and deprivation) are unknown. 
8.2 Coverage 
All children are offered vision screening; this is obligatory within the first 12 months of life 
and optional until 6 years of age. Children are invited via the mother-child-passport 
programme, which is a specific information service for parents and children. This system 
sends letters to parents of children within defined age groups, containing information about 
screening and an invitation to attend a physician clinic within 2 weeks. 
There is no data collected regarding the attendance rate of vision screening before the age 
of 7 years, or the coverage of visual acuity measurements as part of vision screening before 
the age of 7 years. It is estimated that more than 90% of children receive vision screening 
before the age of 7 years, however, the exact data is not accessible.  
The percentage of compliance with referral after an abnormal screening test result is 
unknown and it is unknown if there is registration or documentation of noncompliance with 
referral after an abnormal screening test result. 
8.3 Treatment success 
Glasses are only prescribed for children under the age of 7 years by an ophthalmologist. All 
eligible children with vision disorders are offered treatment. This includes glasses for 
refractive error, occlusion therapy, atropine, cataract or glaucoma operations.  
The percentage of children treated for congenital eye disorders, strabismus and/or 
amblyopia is unknown. It is also not known how many patients are treated for congenital 
cataract, amblyopia and strabismus per year by orthoptists and/or ophthalmologists. 
8.4 Screening evaluation 
The percentage of false negatives and false positives from vision screening is unknown. The 
positive predictive value, sensitivity of vision and specificity of vision screening are all 
unknown.  
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9. Costs of vision screening in children 
In Austria, vision screening is free of charge for parents and there is a financial reward for 
parents whose children attend the vision screening appointment. There is also a penalty for 
parents when children do not attend the vision screening. 
The amount of childcare allowance (KBG) is linked to the correct implementation and proof 
of the first ten Mother-Child-Pass examinations to the health insurance.  
Births from March 1, 2017: If only one examination is not carried out or not proven in time, 
the child care allowance will be deducted in principle 1,300 Euros. If both parents receive 
childcare allowance, deduction of  ? ? ? ? ? ?ǁŝůůďĞŵĂĚĞƚŽĞĂĐŚƉĂƌĞŶƚ ?WƌŽŽĨŽĨƚŚĞĨŝƌƐƚƐŝǆ
examinations must already be made during the application process. The proof of the further 
four investigations must be made by the 15th month of life. 
Births until February 28, 2017: Failure to perform an examination (or multiple 
examinations), late examinations, or failure to provide proof of examinations to the health 
insurer will result in a halving of the childcare allowance. This depends on the type of 
benefit selected from 25, 17, 13, or 10 months of life, or to a reduction of the income-
related KBG amounting to 16.50 Euro per day from 10 months of age. 
It is difficult for the country representative to estimate the costs because there is no 
structured procedure for these conditions in terms of frequency including which the 
children are seen, prices of operations (regional differences) and days at hospitals. 
9.1 Cost of vision screening  
The costs of vision screening are not known.  
9.2 Cost of treatment for amblyopia 
Treatment of typical patients with refractive amblyopia and strabismic amblyopia, including 
follow-up, is estimated at 500 Euros. No further information is provided. 
9.3 Cost of Treatment for strabismus  
The estimated costs for strabismus surgery, including follow-up, is estimated at 2,500 Euros. 
No further information is provided. 
9.4 Cost of treatment for cataract 
The costs for congenital cataract surgery, including follow-up of deprivation amblyopia, is 
estimated at 5,000 Euros. No further information is provided. 
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